| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
136.22(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $543.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
44,753 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,062,766 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
4 |
6 |
7 |
8 |
| Total Sell Transactions |
5 |
8 |
10 |
15 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Peru Ramiro G |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
9,497 |
|
- |
|
| Neri Antonio F |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
4,324 |
|
- |
|
| Clark R Kerry |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
9,039 |
|
- |
|
| Dixon Robert L Jr |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
10,026 |
|
- |
|
| Devore Susan D. |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
1,701 |
|
- |
|
| Schneider Ryan M. |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
5,999 |
|
- |
|
| Hay Lewis III |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
10,906 |
|
- |
|
| Tallett Elizebeth E |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
10,291 |
|
- |
|
| Strable-Soethout Deanna D |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
1,045 |
|
- |
|
| Jallal Bahija |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
4,187 |
|
- |
|
| Norwood Felicia F |
EVP & President,Gov Health Ben |
• – – |
2024-04-24 |
4 |
S |
$532.14 |
$3,300,590 |
D/D |
(6,199) |
27,304 |
|
-3% |
|
| Norwood Felicia F |
EVP & President,Gov Health Ben |
• – – |
2024-04-24 |
4 |
OE |
$238.27 |
$486,786 |
D/D |
2,043 |
33,503 |
|
- |
|
| Norwood Felicia F |
EVP & President,Gov Health Ben |
• – – |
2024-04-23 |
4 |
S |
$533.73 |
$7,531,565 |
D/D |
(14,111) |
31,460 |
|
-3% |
|
| Norwood Felicia F |
EVP & President,Gov Health Ben |
• – – |
2024-04-23 |
4 |
OE |
$238.27 |
$1,304,052 |
D/D |
5,473 |
45,571 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2024-03-08 |
4 |
S |
$500.46 |
$1,217,119 |
D/D |
(2,432) |
15,840 |
|
-9% |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2024-03-06 |
4 |
S |
$504.58 |
$462,195 |
D/D |
(916) |
1,764 |
|
-9% |
|
| Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2024-03-04 |
4 |
AS |
$500.18 |
$10,551,297 |
D/D |
(21,095) |
18,887 |
|
9% |
|
| Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2024-03-04 |
4 |
OE |
$166.97 |
$2,504,550 |
D/D |
15,000 |
39,982 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,272 |
2,680 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2024-03-01 |
4 |
D |
$499.11 |
$191,159 |
D/D |
(383) |
1,408 |
|
- |
|
| Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,557 |
24,982 |
|
- |
|
| Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2024-03-01 |
4 |
D |
$499.11 |
$2,153,161 |
D/D |
(4,314) |
13,425 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,508 |
18,272 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2024-03-01 |
4 |
D |
$499.11 |
$740,679 |
D/D |
(1,484) |
13,764 |
|
- |
|
| Kaye Mark |
EVP & CFO |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,755 |
23,031 |
|
- |
|
1950 Records found
|
|
Page 1 of 78 |
|
|
6.09 (1.11%) 
